201 related articles for article (PubMed ID: 32061912)
1. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
3. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
[TBL] [Abstract][Full Text] [Related]
4. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
5. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways.
Song R; Xiong C; Bai J; Bai Z; Liu W
Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 38258596
[TBL] [Abstract][Full Text] [Related]
7. Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway.
Mao HP; Wang XY; Gao YH; Chang YX; Chen L; Niu ZC; Ai JQ; Gao XM
J Ethnopharmacol; 2016 Jun; 186():20-29. PubMed ID: 26970569
[TBL] [Abstract][Full Text] [Related]
8. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes.
Qi J; Yu J; Tan Y; Chen R; Xu W; Chen Y; Lu J; Liu Q; Wu J; Gu W; Zhang M
Sci Rep; 2017 Feb; 7():42843. PubMed ID: 28205629
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial].
Fu L; Mao ZX; Wang J; Zhang J; Zheng TR; Wang SL
Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):509-13. PubMed ID: 19583930
[TBL] [Abstract][Full Text] [Related]
11. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
12. Kuanxiong aerosol inhibits apoptosis and attenuates isoproterenol-induced myocardial injury through the mitogen-activated protein kinase pathway.
Lu Y; Yang M; Peng M; Xie L; Shen A; Lin S; Huang B; Chu J; Peng J
J Ethnopharmacol; 2021 Apr; 269():113757. PubMed ID: 33359915
[TBL] [Abstract][Full Text] [Related]
13.
Cao YY; Li K; Li Y; Tian XT; Ba HX; Wang A; Li XH
Pharm Biol; 2020 Dec; 58(1):176-183. PubMed ID: 33826488
[TBL] [Abstract][Full Text] [Related]
14. Effect of aliskiren and carvedilol on expression of Ca(2+)/calmodulin-dependent protein kinase II δ-subunit isoforms in cardiac hypertrophy rat model.
Bin-Dayel AF; Abdel Baky NA; Fadda LM; Mohammad RA; Al-Mohanna F
Toxicol Mech Methods; 2016 Feb; 26(2):122-31. PubMed ID: 26982530
[TBL] [Abstract][Full Text] [Related]
15. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway in isoproterenol-induced myocardial hypertrophy.
Yang J; Wang HX; Zhang YJ; Yang YH; Lu ML; Zhang J; Li ST; Zhang SP; Li G
J Ethnopharmacol; 2013 Dec; 150(3):1062-70. PubMed ID: 24432369
[TBL] [Abstract][Full Text] [Related]
17. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
[TBL] [Abstract][Full Text] [Related]
18. The CaMKII phosphorylation site Thr1604 in the Ca
Li J; Wang S; Zhang J; Liu Y; Zheng X; Ding F; Sun X; Zhao M; Hao L
Channels (Austin); 2020 Dec; 14(1):151-162. PubMed ID: 32290730
[TBL] [Abstract][Full Text] [Related]
19. Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.
Wu JB; Zhou Y; Liang CL; Zhang XJ; Lai JM; Ye SF; Ouyang H; Lin J; Zhou JY
Chin J Integr Med; 2017 Oct; 23(10):770-778. PubMed ID: 27048408
[TBL] [Abstract][Full Text] [Related]
20. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats.
Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L
J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
